Levetiracetam Sun

Levetiracetam, the active ingredient in Levetiracetam Sun, is an anticonvulsant presented as a sterile powder for reconstitution for intravenous injection. It is used to manage partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients who require rapid and reliable seizure control.

GNH USA supplies Levetiracetam Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU regulatory standards. The company ensures product quality and traceability from manufacture to delivery through rigorous quality control and cold‑chain logistics where required.

Levetiracetam is an anticonvulsant used to treat several seizure types by modulating neuronal excitability. - Partial-onset seizures: reduces frequency and severity of focal seizures. - Generalized tonic-clonic seizures: helps control convulsive episodes in generalized epilepsy. - Myoclonic seizures: diminishes rapid muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit. - Irritability: mood changes or increased agitation. - Somnolence: excessive sleepiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Hematologic abnormalities: low blood cell counts such as neutropenia. - Mood or behavioral changes: depression, suicidal thoughts, or aggression. - Hepatic dysfunction: elevated liver enzymes or liver injury.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust dose in patients with reduced kidney function. - History of psychiatric disorders: monitor for mood changes or aggression. - Concomitant CNS depressants: use caution as combined effects may increase sedation. - Pregnancy: avoid unless benefits outweigh potential risks, as safety data are limited. - Elderly patients: start at lower doses and titrate slowly due to increased sensitivity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing effectiveness. - Phenobarbital: can lower levetiracetam concentrations, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase risk of adverse CNS effects. - Opioids: combined use may enhance sedation and respiratory depression. - Fluoroquinolones: potential for increased neurotoxicity. - Alcohol: may intensify dizziness and drowsiness.